| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/MukherjeeBR10 |
| P356 | DOI | 10.1021/CI1001982 |
| P932 | PMC publication ID | 3058392 |
| P698 | PubMed publication ID | 21033739 |
| P5875 | ResearchGate publication ID | 47632479 |
| P2093 | author name string | Sudipto Mukherjee | |
| Robert C Rizzo | |||
| Trent E Balius | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| DOCK 6: combining techniques to model RNA-small molecule complexes | Q24657524 | ||
| BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities | Q24675698 | ||
| DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases | Q27231136 | ||
| Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes | Q27642161 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| The Amber biomolecular simulation programs | Q27860745 | ||
| Gaussian docking functions | Q28208578 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Automated docking screens: a feasibility study | Q28256939 | ||
| Community benchmarks for virtual screening | Q28268675 | ||
| Automated docking of flexible ligands: applications of AutoDock | Q28285420 | ||
| Recommendations for evaluation of computational methods | Q28755020 | ||
| Development and testing of a general amber force field | Q29547642 | ||
| Rational design of potent sialidase-based inhibitors of influenza virus replication | Q29616647 | ||
| Improved protein-ligand docking using GOLD | Q29616787 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
| Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation | Q29617869 | ||
| Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase. | Q30333072 | ||
| Novel procedure for modeling ligand/receptor induced fit effects. | Q30352584 | ||
| The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. | Q30356303 | ||
| Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. | Q30370020 | ||
| Ligand-protein database: linking protein-ligand complex structures to binding data | Q30662705 | ||
| Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking | Q30822076 | ||
| Virtual screening of chemical libraries | Q33209939 | ||
| Virtual ligand screening: strategies, perspectives and limitations | Q33247681 | ||
| A geometric approach to macromolecule-ligand interactions | Q34280176 | ||
| The many roles of computation in drug discovery | Q34307063 | ||
| Flexibases: a way to enhance the use of molecular docking methods | Q34319987 | ||
| The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures | Q34323005 | ||
| The PDBbind database: methodologies and updates | Q34424778 | ||
| Development and validation of a modular, extensible docking program: DOCK 5. | Q34588100 | ||
| Structure-based strategies for drug design and discovery | Q35748974 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Soft docking and multiple receptor conformations in virtual screening | Q41968000 | ||
| Bias, reporting, and sharing: computational evaluations of docking methods | Q42639520 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. | Q46036230 | ||
| Molecular docking to ensembles of protein structures | Q46668232 | ||
| Flexible docking allowing induced fit in proteins: insights from an open to closed conformational isomers | Q47625159 | ||
| Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations. | Q51869959 | ||
| A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors. | Q51932664 | ||
| Diverse, high-quality test set for the validation of protein-ligand docking performance. | Q55043208 | ||
| Binding MOAD (Mother Of All Databases) | Q81878003 | ||
| P433 | issue | 11 | |
| P921 | main subject | protein family | Q417841 |
| P304 | page(s) | 1986-2000 | |
| P577 | publication date | 2010-10-29 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| P1476 | title | Docking validation resources: protein family and ligand flexibility experiments | |
| P478 | volume | 50 |
| Q38727350 | A Cu(ii) complex targeting the translocator protein: in vitro and in vivo antitumor potential and mechanistic insights |
| Q90529267 | Chaos-embedded particle swarm optimization approach for protein-ligand docking and virtual screening |
| Q36250876 | Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold. |
| Q92111314 | Comparative Analysis of Electrostatic Models for Ligand Docking |
| Q47918040 | Comprehensive assessment of flexible-ligand docking algorithms: current effectiveness and challenges |
| Q26777448 | Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors |
| Q28730803 | Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms |
| Q33907793 | Computational study on substrate specificity of a novel cysteine protease 1 precursor from Zea mays |
| Q92642434 | Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents |
| Q41931663 | Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets. |
| Q35693426 | DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites |
| Q35748554 | DOCK 6: Impact of new features and current docking performance |
| Q36293001 | Destabilization of strigolactone receptor DWARF14 by binding of ligand and E3-ligase signaling effector DWARF3. |
| Q89694588 | Dimethylaminophenyl Hydrazides as Inhibitors of the Lipid Transport Protein LprG in Mycobacteria |
| Q42849091 | Docking Studies of Methylthiomorpholin Phenols (LQM300 Series) with Angiotensin-Converting Enzyme (ACE). |
| Q33830749 | Effect of Binding Pose and Modeled Structures on SVMGen and GlideScore Enrichment of Chemical Libraries |
| Q92942733 | Effective Estimation of Ligand-Binding Affinity Using Biased Sampling Method |
| Q37518530 | Evaluation of DOCK 6 as a pose generation and database enrichment tool |
| Q51515408 | Exponential repulsion improves structural predictability of molecular docking. |
| Q51424810 | Fast and accurate determination of the relative binding affinities of small compounds to HIV-1 protease using non-equilibrium work. |
| Q34461976 | Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). |
| Q35874697 | Footprint-based identification of viral entry inhibitors targeting HIVgp41. |
| Q47573321 | GalaxyDock2: protein-ligand docking using beta-complex and global optimization |
| Q33590499 | Grid-based molecular footprint comparison method for docking and de novo design: application to HIVgp41 |
| Q64359309 | Identification of Ebola Virus Inhibitors Targeting GP2 using Principles of Molecular Mimicry |
| Q90189700 | Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening |
| Q89429512 | Identification of a Water-Coordinating HER2 Inhibitor by Virtual Screening Using Similarity-Based Scoring |
| Q45323947 | Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein |
| Q35235591 | Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons |
| Q37644156 | Implementation of the Hungarian algorithm to account for ligand symmetry and similarity in structure-based design |
| Q90871426 | Incorporating Explicit Water Molecules and Ligand Conformation Stability in Machine-Learning Scoring Functions |
| Q35140182 | Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. |
| Q26773062 | Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods |
| Q91316158 | Interactions of domain antibody (dAbκ11) with Mycobacterium tuberculosis Ac2SGL in complex with CD1b |
| Q28483059 | IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening |
| Q38092807 | Latest developments in molecular docking: 2010-2011 in review |
| Q55691227 | Ligand Selectivity between the ADP-Ribosylating Toxins: An Inverse-Docking Study for Multitarget Drug Discovery. |
| Q50888328 | Ligand- and receptor-based docking with LiBELa. |
| Q92682023 | Ligands and Receptors with Broad Binding Capabilities Have Common Structural Characteristics: An Antibiotic Design Perspective |
| Q39556441 | Molecular dynamics simulations of acylpeptide hydrolase bound to chlorpyrifosmethyl oxon and dichlorvos |
| Q34486497 | Molecular modeling and MM-PBSA free energy analysis of endo-1,4-β-xylanase from Ruminococcus albus 8 |
| Q30410858 | Molecular-level simulation of pandemic influenza glycoproteins |
| Q58555781 | Novel C15 Triene Triazole, D-A Derivatives Anti-HepG2, and as HDAC2 Inhibitors: A Synergy Study |
| Q35013407 | Pharmacophore-based similarity scoring for DOCK |
| Q91917203 | Predicting and designing therapeutics against the Nipah virus |
| Q26864013 | Protein flexibility in docking and surface mapping |
| Q38589320 | Review structure- and dynamics-based computational design of anticancer drugs |
| Q37552860 | Strategies for lead discovery: application of footprint similarity targeting HIVgp41. |
| Q40118758 | Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase |
| Q92876781 | Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors |
| Q37284895 | Structural properties of non-traditional drug targets present new challenges for virtual screening |
| Q36332768 | Structure-Based Target-Specific Screening Leads to Small-Molecule CaMKII Inhibitors. |
| Q53822434 | Synthesis and Evaluation of C15 Triene Urushiol Derivatives as Potential Anticancer Agents and HDAC2 Inhibitor. |
| Q52594638 | Synthesis and biological evaluation of indole-2-carbohydrazide derivatives as anti-cancer agents with anti-angiogenic and anti-proliferative activities. |
| Q21090833 | Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs |
| Q27676739 | The Impact of Introducing a Histidine into an Apolar Cavity Site on Docking and Ligand Recognition |
| Q35631389 | The role of conformational selection in the molecular recognition of the wild type and mutants XPA67-80 peptides by ERCC1. |
| Q93146100 | The structural and biochemical impacts of monomerizing human acetylcholinesterase |
| Q36647201 | Thiolactomycin-based β-ketoacyl-AcpM synthase A (KasA) inhibitors: fragment-based inhibitor discovery using transient one-dimensional nuclear overhauser effect NMR spectroscopy |
| Q27682088 | Time-Dependent Diaryl Ether Inhibitors of InhA: Structure-Activity Relationship Studies of Enzyme Inhibition, Antibacterial Activity, and in vivo Efficacy |
| Q37246257 | Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosy |
| Q113241747 | spyrmsd: symmetry-corrected RMSD calculations in Python |
Search more.